Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis

被引：32
|
作者：
Nanzer, Alexandra M. [1 ,2 ]
Dhariwal, Jaideep [1 ]
Kavanagh, Joanne [1 ,2 ]
Hearn, Andrew [1 ,2 ]
Fernandes, Mariana [1 ]
Thomson, Louise [1 ]
Roxas, Cris [1 ]
Green, Linda [1 ]
D'Ancona, Grainne [1 ]
Agarwal, Sangita [3 ]
Kent, Brian D. [1 ]
Jackson, David J. [1 ,2 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Guys Severe Asthma Serv, Thorac Med, London, England
[2] Kings Coll London, Sch Immunol & Microbial Sci, London, England
[3] Guys & St Thomas NHS Fdn Trust, Dept Rheumatol, London, England
来源：
ERJ OPEN RESEARCH | 2020年 / 6卷 / 04期
关键词：
MEPOLIZUMAB;
D O I：
10.1183/23120541.00451-2020
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
    Menzella, Francesco
    Galeone, Carla
    Ghidoni, Giulia
    Ruggiero, Patrizia
    Capobelli, Silvia
    Simonazzi, Anna
    Catellani, Chiara
    Scelfo, Chiara
    Livrieri, Francesco
    Facciolongo, Nicola
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2021, 16
  • [42] Off-Label Use of Benralizumab for Severe Eosinophilic Granulomatosis with Polyangiitis
    Gripaldo, R. E. M.
    Specks, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [43] Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
    Kent, Brian D.
    d'Ancona, Grainne
    Fernandes, Mariana
    Green, Linda
    Roxas, Cris
    Thomson, Louise
    Nanzer, Alexandra M.
    Kavanagh, Joanne
    Agarwal, Sangita
    Jackson, David J.
    ERJ OPEN RESEARCH, 2020, 6 (01)
  • [44] ORAL CORTICOSTEROID-SPARING EFFECT OF MEPOLIZUMAB IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Wechsler, M.
    Jayne, D.
    Terrier, B.
    Hellmich, B.
    Bentley, J.
    Steinfeld, J.
    Yancey, S.
    Kwon, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S7 - S7
  • [45] Omalizumab as a Steroid-Sparing Agent in Chronic Eosinophilic Pneumonia
    Kaya, Hatice
    Gumus, Seyfettin
    Ucar, Ergun
    Aydogan, Mehmet
    Musabak, Ugur
    Tozkoparan, Ergun
    Bilgic, Hayati
    CHEST, 2012, 142 (02) : 513 - 516
  • [46] BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): RESULTS FROM A EUROPEAN MULTICENTER STUDY ON 121 PATIENTS
    Bettiol, A.
    Mattioli, I.
    Urban, M. L.
    Bello, F.
    Padoan, R.
    Groh, M.
    Lopalco, G.
    Egan, A.
    Cottin, V.
    Fraticelli, P.
    Crimi, C.
    Del Giacco, S.
    Schroeder, J.
    Moi, L.
    Jayne, D.
    Vaglio, A.
    Emmi, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 196 - 197
  • [47] Effect of Benralizumab versus Mepolizumab on Reduction in Oral Glucocorticoid Use in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Hellmich, B.
    Wechsler, M. E.
    Merkel, P. A.
    Nair, P.
    Bourdin, A.
    Jayne, D. R. W.
    Roufosse, F.
    Sjo, Borjesson L.
    Fan, Y.
    Menzies-Gow, A.
    Necander, S.
    Shavit, A.
    SWISS MEDICAL WEEKLY, 2024, 154 : 32S - 32S
  • [48] Efficacy of Benralizumab and Clinical Course of IgG4 in Eosinophilic Granulomatosis With Polyangiitis
    Miyata, Y.
    Inoue, H.
    Homma, T.
    Tanaka, A.
    Sagara, H.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (04) : 346 - 348
  • [49] Decrease in MPO-ANCA after administration of benralizumab in eosinophilic granulomatosis with polyangiitis
    Takenaka, Kenchi
    Minami, Tomoko
    Yoshihashi, Yoko
    Hirata, Shinya
    Kimura, Yoshitaka
    Kono, Hajime
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (04) : 539 - 540
  • [50] Benralizumab Monotherapy Substitution Therapy in Symptomatic Asthma Exacerbations of Eosinophilic Granulomatosis with Polyangiitis
    Onuigbo, Macaulay A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 825 - 825
12345